Skip to main content
. 2018 Dec 22;11(2):219–238. doi: 10.1080/19420862.2018.1556465

Figure 5.

Figure 5.

Antibodies to watch in 2010–2019.

Data from ‘Antibodies to watch’ articles published in mAbs. 2019 data as of November 2018. Totals include only antibody therapeutics sponsored by commercial firms; those sponsored solely by government, academic or non-profit organizations were excluded. Tables of mAbs in late-stage studies are available at www.antibodysociety.org.